Glycoconjugates enhanced the intracellular killing of Bacillus spores, increasing macrophage viability and activation

被引:9
作者
Tarasenko, Olga [1 ]
Soderberg, Lee [3 ]
Hester, Kristin [1 ]
Kim, Michelle Park [1 ]
McManus, Deirdre [1 ]
Alusta, Pierre [2 ]
机构
[1] Univ Arkansas, Dept Biol, Little Rock, AR 72204 USA
[2] Univ Arkansas, Dept Chem, Little Rock, AR 72204 USA
[3] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA
关键词
glycoconjugate; macrophage; phagocytosis; prior to; during; and following exposure to B. cereus spores; nitric oxide;
D O I
10.1007/s00203-008-0352-z
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Infections caused by Bacillus spores can be attenuated if the intracellular killing of the organism by macrophages can be enhanced. Glycoconjugate-bearing polymers, which selectively bind to Bacillus spores, were tested for modulation of intracellular killing when added prior to, during, and following macrophage exposure to B. cereus spores. In the absence of glycoconjugates, murine macrophages were ineffective at killing Bacillus spores. In presence of glycoconjugates, however, macrophages efficiently killed spores, whether the glycoconjugates were added to the cells prior to, during, and following spore addition. Glycoconjugates were shown to exert a protective influence on macrophages and increase their activation, as evidenced by viability and lactate dehydrogenase release assays. Increased levels of nitric oxide production by macrophages pretreated with glycoconjugates suggest that, under these conditions, glycoconjugates provide an activation signal to macrophages. These results indicate that glycoconjugates promote killing of Bacillus spores, while increasing macrophage activation level and viability. The selection of glycoconjugate ligands bearing immunomodulating properties could be exploited for vaccine and/or immunomodulator development and/or for the improvement of existing vaccines against B. cereus and B. anthracis.
引用
收藏
页码:579 / 587
页数:9
相关论文
共 52 条
  • [1] ANDERSON PW, 1989, J IMMUNOL, V142, P2464
  • [2] [Anonymous], 1997, GLYCOSCIENCES STATUS
  • [3] ASH C, 1992, FEMS MICROBIOL LETT, V94, P75
  • [4] COMPARATIVE-ANALYSIS OF BACILLUS-ANTHRACIS, BACILLUS-CEREUS, AND RELATED SPECIES ON THE BASIS OF REVERSE-TRANSCRIPTASE SEQUENCING OF 16S RIBOSOMAL-RNA
    ASH, C
    FARROW, JAE
    DORSCH, M
    STACKEBRANDT, E
    COLLINS, MD
    [J]. INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1991, 41 (03): : 343 - 346
  • [5] The impact of glycobiology on medicine
    Axford, J
    [J]. TRENDS IN IMMUNOLOGY, 2001, 22 (05) : 237 - 239
  • [6] Bacillus anthracis, a bug with attitude!
    Baillie, L
    Read, TD
    [J]. CURRENT OPINION IN MICROBIOLOGY, 2001, 4 (01) : 78 - 81
  • [7] BARNABY W, 1997, PLAGUE MARKERS SECRE
  • [8] THE NITRIC-OXIDE DONORS, AZIDE AND HYDROXYLAMINE, INHIBIT THE PROGRAMMED CELL-DEATH OF CYTOKINE-DEPRIVED HUMAN EOSINOPHILS
    BEAUVAIS, F
    MICHEL, L
    DUBERTRET, L
    [J]. FEBS LETTERS, 1995, 361 (2-3) : 229 - 232
  • [9] Chemical glycobiology
    Bertozzi, CR
    Kiessling, LL
    [J]. SCIENCE, 2001, 291 (5512) : 2357 - 2364
  • [10] BLACK JG, 2005, MICROBIOLOGY PRINCIP, P463